94 related articles for article (PubMed ID: 18556403)
1. A possible role of 18F-FDG positron-emission tomography scanning in the early detection of rituximab-induced pneumonitis in patients with non-Hodgkin's lymphoma.
Nieuwenhuizen L; Verzijlbergen FJ; Wiltink E; Grutters JC; Biesma DH
Haematologica; 2008 Aug; 93(8):1267-9. PubMed ID: 18556403
[No Abstract] [Full Text] [Related]
2. Rituximab-induced pneumonitis on F-18 FDG PET/CT in patient with non-Hodgkin lymphoma.
Song BI; Lee SW; Lee HJ; Kang S; Jeong SY; Seo JH; Ahn BC; Lee J; Shin KM
Clin Nucl Med; 2010 Aug; 35(8):601-3. PubMed ID: 20631510
[No Abstract] [Full Text] [Related]
3. Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
Reilly TB; Schuster DM; Starsiak MD; Kost CB; Halkar RK
Clin Nucl Med; 2007 Jul; 32(7):569-71. PubMed ID: 17581351
[No Abstract] [Full Text] [Related]
4. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin's and non-Hodgkin's lymphomas.
Rademaker J
Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy.
Shih WJ; Ghesani N; Hongming Z; Alavi A; Schusper S; Mozley D
Clin Nucl Med; 2002 Feb; 27(2):142-3. PubMed ID: 11786752
[No Abstract] [Full Text] [Related]
7. False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
Inoue Y; Tamaki H; Yamagami T; Iwasaki H; Nakatsuka S; Soma T
Eur J Haematol; 2007 Jul; 79(1):88-90. PubMed ID: 17532762
[No Abstract] [Full Text] [Related]
8. [18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy.
Kalkanis D; Stefanovic A; Paes F; Escalon MP; Serafini A; Lossos IS
Leuk Lymphoma; 2009 Jun; 50(6):904-11. PubMed ID: 19455459
[TBL] [Abstract][Full Text] [Related]
9. Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
Herrmann K; Wieder HA; Buck AK; Schöffel M; Krause BJ; Fend F; Schuster T; Meyer zum Büschenfelde C; Wester HJ; Duyster J; Peschel C; Schwaiger M; Dechow T
Clin Cancer Res; 2007 Jun; 13(12):3552-8. PubMed ID: 17575218
[TBL] [Abstract][Full Text] [Related]
10. Incidental findings on follow-up fluorodeoxyglucose positron emission tomography studies in lymphoma patients: beware the outlier.
Aide N; Irving L; Hicks RJ
Leuk Lymphoma; 2009 Jun; 50(6):865-7. PubMed ID: 19504393
[No Abstract] [Full Text] [Related]
11. Recurrent psychotic episodes in a patient who received rituximab for the treatment of non-Hodgkin's lymphoma.
Kami M; Hamaki T; Kusumi E; Iwata H; Ueyama J; Morinaga S; Miyakoshi S; Taniguchi S; Muto Y
Hematol J; 2004; 5(1):90. PubMed ID: 14745437
[No Abstract] [Full Text] [Related]
12. 18F-FDG positron emission tomography scan findings in a case of rituximab-CHOP-induced pneumonitis.
Saini N; Saini V; Kumar V; Bhatia A; Qazi S
Indian J Cancer; 2015; 52(3):437-8. PubMed ID: 26905161
[No Abstract] [Full Text] [Related]
13. Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.
Spaepen K; Mortelmans L
Q J Nucl Med; 2001 Sep; 45(3):269-73. PubMed ID: 11788819
[TBL] [Abstract][Full Text] [Related]
14. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract][Full Text] [Related]
15. [18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography for early evaluation of treatment efficacy in advanced non-Hodgkin lymphoma of uterine corpus: a case report.
Imperiale A; Blondet C; Fohrer C; Cimarelli S; Herbrecht R; Constantinesco A
Clin Lymphoma Myeloma; 2007 May; 7(6):421-4. PubMed ID: 17621408
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
Juweid ME
J Nucl Med; 2008 Jan; 49(1):9-12. PubMed ID: 18077522
[No Abstract] [Full Text] [Related]
17. A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid.
Bibb J; Hromas R; Rabinowitz I
J Clin Oncol; 2005 Dec; 23(34):8911-3. PubMed ID: 16314654
[No Abstract] [Full Text] [Related]
18. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
Chiusolo P; Sica S; Leone G
Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
[TBL] [Abstract][Full Text] [Related]
19. Fatal interstitial pneumonitis related to rituximab-containing regimen.
Herishanu Y; Polliack A; Leider-Trejo L; Grieff Y; Metser U; Naparstek E
Clin Lymphoma Myeloma; 2006 Mar; 6(5):407-9. PubMed ID: 16640819
[TBL] [Abstract][Full Text] [Related]
20. FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis.
Kirsch J; Arrossi AV; Yoon JK; Wu G; Neumann DR
J Thorac Imaging; 2006 Aug; 21(3):228-30. PubMed ID: 16915070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
